Patents by Inventor Henry V. Huang

Henry V. Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5869296
    Abstract: A novel transposon useful for sequencing long DNAs is disclosed which comprises a partial sequence of transposon Tn5 with the oligonucleotide primers from phages SP6 and T7 inserted near the opposite ends, respectively, of said transposon Tn5.
    Type: Grant
    Filed: January 14, 1993
    Date of Patent: February 9, 1999
    Assignee: Washington University
    Inventors: Dilip K. Nag, Henry V. Huang, Douglas E. Berg
  • Patent number: 5316946
    Abstract: A small, novel transposon useful for mutagenesis and sequencing DNAs cloned in phage .lambda. is disclosed which comprises a transposon having at each terminus a segment of 19 nucleotides selected from the group consisting of the O-end and I-end sequences of Tn5, at least one restriction enzyme site positioned less that 20 nucleotides distant from each said terminal segment, and a supF amber-suppressor tRNA gene insert.
    Type: Grant
    Filed: January 22, 1990
    Date of Patent: May 31, 1994
    Assignee: Washington University
    Inventors: Suhas H. Phadnis, Henry V. Huang, Doulgas E. Berg
  • Patent number: 5217879
    Abstract: Compositions and methods are disclosed for expressing heterologous coding sequences in host cells. The compositions include infectious Sindbis virus RNA molecules containing at least one heterologous coding sequence inserted within the structural region of the Sindbis virus genome. RNA molecules consisting essentially of a Sindbis virus junction region are also provided. Methods utilizing the novel compositions of the present invention to express heterologous coding sequences in transformed host cells are provided. Methods for producing infectious Sindbis virus particles containing infectious Sindbis virus RNA molecules comprising at least one heterologous coding sequence are provided.This invention was made with government support under grant numbers AI24134, AI11377 and AG05681 awarded by the National Institutes of Health. The government has certain rights in the invention.
    Type: Grant
    Filed: December 27, 1991
    Date of Patent: June 8, 1993
    Assignee: Washington University
    Inventors: Henry V. Huang, Robin Levis, Charles M. Rice, Sondra Schlesinger, Ping Shen, Cheng Xiong
  • Patent number: 5212080
    Abstract: A novel transposon useful for sequencing long DNAs is disclosed which comprises a partial sequence of transposon Tn5 with the oligonucleotide primers from phages SP6 and T7 inserted near the opposite ends, respectively, of said transposon Tn5.
    Type: Grant
    Filed: April 12, 1990
    Date of Patent: May 18, 1993
    Assignee: Washington University
    Inventors: Dilip K. Nag, Henry V. Huang, Douglas E. Berg
  • Patent number: 5137829
    Abstract: A novel transposon useful for sequencing long DNAs is disclosed which comprises a partial sequence of transposon Tn5 with the oligonucleotide primers from phages SP6 and T7 inserted near the opposite ends, respectively, of said transposon Tn5.
    Type: Grant
    Filed: October 5, 1987
    Date of Patent: August 11, 1992
    Assignee: Washington University
    Inventors: Dilip K. Nag, Henry V. Huang, Douglas E. Berg
  • Patent number: 5091309
    Abstract: The present invention relates to RNA vectors comprising Sindbis virus DI RNA having inserted therein heterologous RNA. The vectors of the present invention provide for the cloning and expression of heterologous RNA in eucaryotic cells as well as the packaging of heterologous RNA into viral particles in the presence of helper virus. Transformed cells and genetically altered alphavirus particles comprising alphavirus DI RNA having inserted therein heterologous RNA are also provided.
    Type: Grant
    Filed: August 17, 1989
    Date of Patent: February 25, 1992
    Assignee: Washington University
    Inventors: Sondra Schlesinger, Henry V. Huang, Robin Levis, Barbara Weiss, Manuel Tsiang
  • Patent number: 4327073
    Abstract: A method for the simultaneous and rapid quantitative analysis of biological fluids for a plurality of substances, each of which undergoes at least one reaction with a respective cognate compound. Typical substances include hormones, enzymes, and viruses. The method comprises binding each of a plurality of the respective reactive compounds onto a preselected area of a substrate carrier; e.g., to a band or spot on a carrier film and exposing the sensitized carrier to a sample of the biological fluid to permit the unknown substances contained therein to react with their respective cognate compound which is immobilized on the carrier and then removing excess of the sample from the carrier and developing the carrier and measuring the concentration of the reaction products that are at preselected areas of the carrier.
    Type: Grant
    Filed: April 7, 1980
    Date of Patent: April 27, 1982
    Inventor: Henry V. Huang